Impact of pharmacist-led guideline based patient care on clinical and humanistic outcomes in chronic obstructive pulmonary disease

•        Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition characterized by persistent obstruction of airflow through the lungs and associated symptoms. The number of global prevalent cases of COPD increased from 100.54 million in 1990 to 213.39 million in 2021.  And in India, it is estimated at approximately 7.4%.  It is one of the top three causes of death worldwide and 90% of this death occurs in low- and middle-income countries. The Global Initiative for Obstruction and Prevention of Lung Disease (GOLD) is the standard guideline for diagnosis, management and prevention of COPD. In India, the provision of pharmaceutical care lacks in many of the pulmonary clinics, leading to suboptimal medication management, poor disease control and clinical outcomes’ patients require a long term follow up by healthcare professional for their wellbeing. Despite major advances in the medical care, COPD treatment is still challenging due to lack of personalized patient care, regular monitoring and follow up. With this background, the proposed study aims to provide a guideline-based service through pharmacist-led care, with continuous monitoring and follow-up, to assess its impact on clinical and humanistic outcomes